The DHHS OIG staff just issued an analysis (http://oig.hhs.gov/oei/reports/oei-07-08-00150.asp) claiming frequent misuse of Atypical Antipsychotic drugs in the NF population. Based on a 2007 sample, their summary says:
For the period January 1 through June 30, 2007, we determined using medical record review that 51 percent of Medicare claims for atypical antipsychotic drugs were erroneous, amounting to $116 million.
A member of Congress requested that OIG evaluate the extent to which elderly nursing home residents receive atypical antipsychotic drugs and the associated cost to Medicare. Specifically, this member expressed concern with atypical antipsychotic drugs prescribed to elderly nursing home residents for off-label conditions (i.e., conditions other than schizophrenia and/or bipolar disorder) and/or in the presence of the condition specified in the Food and Drug Administration's (FDA) boxed warning (i.e., dementia). Medicare requires that drugs be prescribed for "medically accepted indications" for reimbursement. Further, CMS sets standards to ensure that nursing home residents' drug therapy regimens are free from unnecessary drugs.
Geriatric Practice Management (GPM) provides physician management services to long-term care practices, with roots in the Asheville, NC area going back 30 years. GPM was established in 2000 to provide geriatric physician practices administrative and technical support and policy guidance. 